Document is current
Any future updates will be listed below
-
Authors
Cooper, Sandra T. https://orcid.org/0000-0002-7314-5097
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (MRF2015930)
- License Information
-
More Information
Article History
First Online: 1 April 2025
Change Date: 24 April 2025
Change Type: Update
Change Details: In the version of this article initially published, in the legend to Fig. , definitions of “Dotted traces” and “filled traces,” as current, respectively, were originally in the wrong order and are now amended in the HTML and PDF versions of the article.
Competing interests
: S.T.C. is a volunteer member of ClinGen Expert Panels: Muscular Dystrophies and Myopathies GCEP and Limb Girdle Muscular Dystrophy VCEP. S.T.C. is named inventor of intellectual property (IP) relating to novel methods to identify splicing variants: 1) WO2020097660A1, inventors S. Cooper and H. Joshi; 2) WO2020/181333, inventor S. Cooper. This IP is owned jointly by The University of Sydney and Sydney Children’s Hospitals Network. S.T.C. is director of Frontier Genomics Pty Australia, which has licensed this IP. S.T.C. currently receives no remuneration for this director role.
